Anne Demulder

1.7k total citations
52 papers, 1.2k citations indexed

About

Anne Demulder is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Anne Demulder has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Anne Demulder's work include Bone health and treatments (10 papers), Bone Metabolism and Diseases (8 papers) and Hemoglobinopathies and Related Disorders (7 papers). Anne Demulder is often cited by papers focused on Bone health and treatments (10 papers), Bone Metabolism and Diseases (8 papers) and Hemoglobinopathies and Related Disorders (7 papers). Anne Demulder collaborates with scholars based in Belgium, United States and France. Anne Demulder's co-authors include G. David Roodman, Yasuyoshi Ohsaki, Frederick R. Singer, Laurence Rozen, Francis Corazza, Alina Ferster, Noriyoshi Kurihara, Akiko Kukita, J.F. Smith and D. Hosking and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Endocrinology.

In The Last Decade

Anne Demulder

46 papers receiving 1.2k citations

Peers

Countries citing papers authored by Anne Demulder

Since Specialization

Citations

This map shows the geographic impact of Anne Demulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Demulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Demulder more than expected).

Fields of papers citing papers by Anne Demulder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Demulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Demulder. The network helps show where Anne Demulder may publish in the future.

Co-authorship network of co-authors of Anne Demulder

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Demulder. A scholar is included among the top collaborators of Anne Demulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Demulder. Anne Demulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiphospholipid antibodies positivity as a potential risk factor for restenosis following arteriovenous fistula stenting in hemodialysis patients: a pilot study 2025 ·Frontiers in Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Frédéric Collart, Anne Demulder, Joëlle Nortier	2
2	Prediction of biological evolution following blood product transfusion during liver transplantation: the contribution of machine learning to decision-making 2025 ·BMJ Health & Care Informatics ·(unknown), (unknown), (unknown), Valério Lucidi, Éric Savier, (unknown), (unknown), Patrizia Loi, (unknown), Anne Demulder, Jacques Créteur, (unknown)	0
3	Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature 2024 ·Antibodies ·(unknown), (unknown), (unknown), (unknown), Anne Demulder, Joëlle Nortier	6
4	Acquired factor XIII deficiency 2023 ·PubMed ·(unknown), (unknown), Anne Demulder, (unknown)	2
5	Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation? 2019 ·Journal of Clinical Medicine ·Laurence Rozen, Denis F. Noubouossie, Laurence Dedeken, Phu-Quoc Lê, Alina Ferster, Anne Demulder	2
6	Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable? 2016 ·Journal of Cardiothoracic and Vascular Anesthesia ·Ariane Willems, (unknown), David Faraoni, A. De Villé, Laurence Rozen, Anne Demulder, Philippe Van der Linden	7
7	Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease 2015 ·European Journal of Anaesthesiology ·Laurence Rozen, David Faraoni, Cristel Sanchez Torres, Ariane Willems, (unknown), (unknown), Philippe Van der Linden, Anne Demulder	17
8	Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease 2014 ·Blood Coagulation & Fibrinolysis ·David Faraoni, Laurence Rozen, Ariane Willems, Cristel Sanchez Torres, Luis M. Pereira, Anne Demulder, Philippe Van der Linden	14
9	Transient leukemia in a newborn without Down syndrome: case report and review of the literature 2013 ·European Journal of Pediatrics ·Laurence Rozen, Sophie Huybrechts, Laurence Dedeken, Cathérine Heijmans, Barbara Dessars, Pierre Heimann, Frédéric Lambert, Denis F. Noubouossie, Alina Ferster, Anne Demulder	11
10	Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children 2011 ·American Journal of Hematology ·Denis F. Noubouossie, Phu-Quoc Lê, Francis Corazza, France Debaugnies, Laurence Rozen, Alina Ferster, Anne Demulder	32
11	Vitamin B12 deficiency in a 9-month-old boy 2011 ·European Journal of Pediatrics ·Christine Quentin, Sophie Huybrechts, Laurence Rozen, Corinne De Laet, Anne Demulder, Alina Ferster	18
12	Osteoprotegerin and Progression of Coronary and Aortic Calcifications in Chronic Kidney Disease 2010 ·Transplantation Proceedings ·(unknown), Anne Demulder, Fleur Wolff, Christian Mélot, Nasroolla Damry, Max Dratwa, Pierre Bergmann	12
13	Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay 2010 ·Thrombosis Research ·France Debaugnies, (unknown), Denis F. Noubouossie, Laurence Rozen, H.C. Hemker, Francis Corazza, André Efira, Anne Demulder	22
14	Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis 2009 ·Clinical Therapeutics ·(unknown), (unknown), (unknown), Denis F. Noubouossie, Anne Demulder	2
15	Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease 2009 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Anne Demulder, Nasroolla Damry, Christian Mélot, (unknown), Dominique Willems, Max Dratwa, Pierre Bergmann	43
16	OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis 2006 ·Clinical Biochemistry ·(unknown), (unknown), Anne Demulder, (unknown), (unknown), Christian Mélot, Max Dratwa, Pierre Bergmann	8
17	Bone Marrow Stroma Damage Induced by Chemotherapy for Acute Lymphoblastic Leukemia in Children 2003 ·Pediatric Research ·Francis Corazza, Christophe Hermans, Alina Ferster, Pierre Fondu, Anne Demulder, Eric Sariban	21
18	Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders?☆ 2000 ·Peptides ·(unknown), Anne Demulder, Frank El Ouriaghli, Francis Corazza, Pierre Fondu, Pierre Bergmann	46
19	Increased Osteoclast-Like Cells Formation in Long-Term Bone Marrow Cultures from Patients with a Spinal Cord Injury 1998 ·Calcified Tissue International ·Anne Demulder, (unknown), Ahmed Ismail, (unknown), Pierre Fondu, Pierre Bergmann	33
20	Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. 1992 ·Journal of Clinical Investigation ·G. David Roodman, Noriyoshi Kurihara, Yasuyoshi Ohsaki, Akiko Kukita, D. Hosking, Anne Demulder, J.F. Smith, Frederick R. Singer	299

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact